Compare VUZI & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VUZI | NAGE |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 217.9M | 239.0M |
| IPO Year | 2009 | 2010 |
| Metric | VUZI | NAGE |
|---|---|---|
| Price | $3.01 | $3.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 542.2K | 342.4K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 61.11 | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | $6,280,611.00 | ★ $129,423,000.00 |
| Revenue This Year | $103.32 | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $33.17 |
| Revenue Growth | 9.14 | ★ 29.95 |
| 52 Week Low | $1.97 | $2.87 |
| 52 Week High | $5.62 | $10.52 |
| Indicator | VUZI | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 66.70 | 41.67 |
| Support Level | $2.96 | $2.96 |
| Resistance Level | $3.19 | $3.61 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 96.85 | 24.14 |
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices and third-party original design manufacturer (ODM) and original equipment manufacturer (OEM) devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.